Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- NA
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias
- Status
- WITHDRAWN
- Phase
- PHASE1
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies
- Status
- UNKNOWN
- Phase
- NA
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
ChiCGB vs BEAM in High-risk or R/R Lymphomas
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Status
- RECRUITING
- Phase
- PHASE1
GM-CLAG in Relapsed/Refractory FLT3-mutated AML
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Venetoclax to Augment Epigenetic Modification and Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE1
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2